Dynavax Patents definition

Dynavax Patents means any Patents Controlled by Dynavax or its Affiliates as of the Effective Date or during the Term that are [ * ] for the research, development, manufacture, importation, use or sale of the Dynavax ISS, Collaboration ISS, Product or Combination Product(s), including without limitation, the Patents listed on Exhibit B, excluding the Collaboration Patents and the AstraZeneca Patents.
Sample 1Sample 2Sample 3
Dynavax Patents means (a) all patents and patent applications in the Territory owned, co-owned, controlled by Dynavax or any of its Affiliates or under which Dynavax or any of its Affiliates has a license or right to practice with the right to extend such license or right to practice to UCB (including all patents and patent applications licensed to Dynavax or any of its Affiliates under the Primary License Agreement) which contain claims or disclosures the rights to which are actually useful or reasonably necessary for the development, manufacturing or using of ISS, or the development, registration, manufacturing, using or selling of Conjugated ISS, Combination ISS or the Licensed Products which are filed as of the Effective Date or during the term of this Agreement, including any addition, continuation, continuation-in-part or division thereof or any substitute application thereof; (b) any patent issued with respect to such patent application, any reissue, extension, patent term extension, supplementary protection certificate or the like of any such patent, and any confirmation patent or registration patent or patent of addition based on any such patent; and (c) any other United States or foreign patent or inventor's certificate relating to any of the foregoing. Dynavax Patents shall include, without limitation, those listed in Exhibit A attached hereto.
Sample 1Sample 2
Dynavax Patents means all patents and patent applications in the Territory owned or controlled by Dynavax or under which Dynavax has a right to practice with the right to extend such right to practice to Triangle (including, but not limited to, all patents and patent applications licensed to Dynavax under the Primary License Agreement) which contain claims the rights to which are reasonably useful for the development, registration, manufacturing, using or selling of Compound ISS or the Licensed Products which are filed as of the Effective Date or during the term of this Agreement provided, that such claims cover inventions or discoveries reduced to practice, actually or constructively, prior to the first anniversary of the expiration of the Research Program, including any addition, continuation, continuation-in-part or division thereof or any substitute application thereof; any patent issued with respect to such patent application, any reissue, extension or patent term extension of any such patent, and any confirmation patent or registration patent or patent of addition based on any such patent; and any other United States and foreign patent or inventor's certificate with regard thereto. Dynavax Patents shall include but not be limited to those listed in Exhibit A attached hereto. Dynavax shall notify Triangle in writing of additions or changes to the Dynavax patents and any proceedings or interference related thereto. It is the parties' intention that Exhibit A identify all Dynavax Patents; however, the omission of a particular patent or patent application from Exhibit A shall not affect the scope of the definition of "Dynavax Patents".
Sample 1

Examples of Dynavax Patents in a sentence

  • The carrying amount of the former subsidiary's assets and liabilities.3. There is no scope limitation within Statement 160 in applying the above guidance except with respect to a nonreciprocal transfer to owners, which is accounted for in accordance with Opinion 29.

  • UCB shall reasonably cooperate with Dynavax in any suit or legal action against infringement of the Dynavax Patents in the Fields, including joining as a named party thereto, if necessary to maintain such suit.

  • UCB acknowledges that the portion of the Dynavax Patents and Dynavax Know-How licensed to Dynavax under the Primary License Agreement were developed with financial or other assistance through grants or contracts funded by the United States government.

  • In the event that applicable law in any other country of the Territory hereafter provides for the extension of the term of any patent included among the Dynavax Patents in such country, upon request by UCB, Dynavax shall authorize UCB and shall use reasonable efforts to obtain the Primary Licensor's authorization for UCB or, if requested by UCB, its sublicensees, to apply for such extension, in consultation with Dynavax and the Primary Licensor.

  • UCB acknowledges that its license rights to such portion of the Dynavax Patents and Dynavax Know-How are subject to the rights of the United States government pursuant to 35 U.S.C. Sections 200-212 and applicable regulations promulgated thereunder.

  • It conducts regular audits of management, financial statements and usage of human resources of the Association.

  • If Dynavax decides to abandon any Dynavax Patents, AstraZeneca shall have the option to continue the prosecution and maintenance of such patents and related applications at its expense.

  • Dynavax shall enable UCB and its internal and external counsel to directly contact and confer with Dynavax's patent attorney with respect to the prosecution of any patent applications constituting part of the Dynavax Patents and shall use its reasonable efforts to amend, correct or refile any patent or patent application included in the Dynavax Patents [***], provided, however, that [***].

  • In the event UCB institutes any action relating to infringement of the Dynavax Patents, UCB may deposit [***] [***]=CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED WITH BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

  • Dynavax shall bear one hundred percent (100%) of the costs and expenses of the Dynavax Patents.


More Definitions of Dynavax Patents

Dynavax Patents means all patents and patent applications in the Territory owned or controlled by Dynavax or under which Dynavax has a right to practice with the right to extend such right to practice to Triangle (including, but not limited to, all patents and patent applications licensed to Dynavax under the Primary License Agreement) which contain claims the rights to which are reasonably necessary for the development, registration, manufacturing, using or selling of ISS, Conjugated ISS or the Licensed Products which are filed as of the Effective Date or during the term of this Agreement provided, that such claims cover inventions or discoveries reduced to practice, actually or constructively, prior to the first anniversary of the expiration of the Research Program, including any addition, continuation, continuation-in-part or division thereof or any substitute application thereof; any patent issued with respect to such patent application, any reissue, extension or patent term extension of any such patent, and any confirmation patent or registration patent or patent of addition based on any such patent; and any other United States and foreign patent or inventor's certificate with regard thereto. Dynavax Patents shall include but not be limited to those listed in Exhibit A attached hereto.
Sample 1
Dynavax Patents means (a) all patents and patent applications in the Territory owned, co-owned, controlled by Dynavax or any of its Affiliates or under which Dynavax or any of its Affiliates has a license or right to practice with the right to extend such license or right to practice to UCB (including all patents and patent applications licensed to Dynavax or any of its Affiliates under the Primary License Agreement) which contain claims or disclosures the rights to which are actually useful or reasonably necessary for the development, manufacturing or using of ISS, or the development, registration, manufacturing, using or selling of Conjugated ISS, Combination ISS or the Licensed Products which are filed as of the Effective Date or during the term of this Agreement, including any addition, continuation,
Sample 1

Related to Dynavax Patents

  • Patent Rights means the rights and interests in and to issued patents and pending patent applications (which, for purposes of this Agreement, include certificates of invention, applications for certificates of invention and priority rights) in any country or region, including all provisional applications, substitutions, continuations, continuations-in-part, divisions, renewals, all letters patent granted thereon, and all reissues, re-examinations and extensions thereof, and all foreign counterparts of any of the foregoing.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Licensed Patent Rights means:

  • Joint Patent Rights means all Patent Rights claiming a Joint Invention.

  • Program Patent Rights means all Patent Rights that claim or cover patentable Program Know-How, including any Program-Specific Patent Rights.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Product Patents means any Patent Controlled or owned by Quoin in the Territory that, absent the license in Section 2.1, would be infringed by the importation, sale, or use of the Product in the Territory by a third party.

  • Joint Patents means all Patents claiming Joint Inventions.

  • Licensee Patents means all of the Patents Controlled by Licensee, its Sublicensees, or any of its or their respective Affiliates as of the Effective Date or during the Term that are necessary (or, with respect to patent applications, would be necessary if such patent applications were to issue as patents) for the Exploitation of a Licensed Product in the Field in the Territory.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Company Patents means Patents owned by the Company or used or held for use by the Company in the Business.

  • Regents' Patent Rights means any of the following: the U.S. patent application, serial number [***], entitled [***] disclosing and claiming the Invention, filed by Inventors and assigned to THE REGENTS; and continuing applications thereof including divisions, substitutions, and continuations-in-part (but only to extent the claims thereof are enabled by disclosure of the parent application); any patents issuing on said applications including reissues, reexaminations and extensions; and any corresponding foreign applications or patents.

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Assigned Patent Rights means all of the following, whether now owned or hereafter acquired or arising:

  • Joint Patent means a Patent that claims a Joint Invention.

  • Patent means (a) all patents and patent applications in any country or supranational jurisdiction in the Territory, (b) any substitutions, divisionals, continuations, continuations-in-part, provisional applications, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates and the like of any such patents or patent applications, and (c) foreign counterparts of any of the foregoing.

  • Licensed IP means the Intellectual Property owned by any person other than the Corporation and to which the Corporation has a license which has not expired or been terminated;

  • Valid Patent Claim means a claim of an issued and unexpired Patent which has not been disclaimed, revoked, held unenforceable or invalid by a decision of a court or other governmental agency of competent jurisdiction, unappealable or unappealed within the time allowed for appeal, and which has not been admitted to be invalid or unenforceable through reissue or disclaimer or otherwise.

  • Patents means all patents, patent applications and like protections including without limitation improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of the same.

  • Patent Applications means all published and unpublished nonprovisional and provisional patent applications, reexamination proceedings, invention disclosures and records of invention, applications for certificates of invention and priority rights, in any country and regardless of formal name, including without limitation, substitutions, continuations, continuations-in-part, divisions, renewals, revivals, reissues, re-examinations and extensions thereof.

  • Product Technology means the Product Know-How and Product Patents.

  • Licensor Technology means the Licensor Patents, the Licensor Know-How, Licensor Materials, Product IP, and Licensor’s rights in the Program IP and Joint Patents.

  • Joint IP means Joint Know-How and Joint Patent Rights.

  • Third Party Technology means all Intellectual Property and products owned by third parties and licensed pursuant to Third Party Licenses.

  • Licensed IP Rights means, collectively, the Licensed Patent Rights and the Licensed Know-How Rights.